Equities

Kindly MD Inc

KDLY:NAQ

Kindly MD Inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.20
  • Today's Change-0.073 / -5.70%
  • Shares traded32.40k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Kindly MD Inc had revenues remain flat at 3.79m, though the company grew net income from a loss of 2.54m to a smaller loss of 1.62m. A reduction in the selling, general and administrative costs as a percentage of sales from 167.10% to 134.19% was a component in the net income growth despite flat revenues.
Gross margin93.94%
Net profit margin-78.86%
Operating margin-68.42%
Return on assets-77.81%
Return on equity-113.00%
Return on investment-99.26%
More ▼

Cash flow in USDView more

In 2023, Kindly MD Inc increased its cash reserves by 181.14%, or 338.58k. Cash Flow from Financing totalled 802.49k or 21.29% of revenues. In addition the company used 449.49k for operations while cash used for investing totalled 14.42k.
Cash flow per share-0.4335
Price/Cash flow per share--
Book value per share0.7376
Tangible book value per share0.7376
More ▼

Balance sheet in USDView more

Kindly MD Inc has a Debt to Total Capital ratio of 5.17%.
Current ratio5.36
Quick ratio5.36
Total debt/total equity0.0545
Total debt/total capital0.0517
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 36.33%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
21.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.